5 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 5 of 5 clinical reviews.
A detailed clinical guide to the delayed-onset adverse effects of pioglitazone (Actos), including fluid retention, bladder cancer risk, bone fractures, and macular edema, with trial data, FDA label citations, and monitoring recommendations.
A guide to pioglitazone adverse events, what happens when you stop Actos, and how to manage discontinuation safely.
A detailed breakdown of pioglitazone (Actos) adverse event incidence rates from major clinical trials, the FDA label, FAERS data, and post-market literature, prepared by the HealthRX.com Editorial Team.
Pioglitazone has important FDA-labeled risks. Learn the warning signs, why individual risk assessment matters, and how to use the current label rather than internet thresholds.
A clinical breakdown of pioglitazone adverse events by severity tier and patient phenotype, drawing on PROactive, RECORD, FAERS data, and ADA guidelines to help prescribers and patients understand who faces the highest risk.